# DALBAVANCIN HYDROCHLORIDE
> **ANDA219604** · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2026-06-04
## Drug
- **FDA Application Number:** ANDA219604
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DALBAVANCIN HYDROCHLORIDE
- **Generic name:** DALBAVANCIN
- **Active ingredients:** DALBAVANCIN HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BE PHARMS
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2026-06-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219604)
---
*MORVS · CC0 1.0*